Skip to content

DMT: all studies

Page 29 of 160: studies 281 to 290 of 1,593, newest first. Back to the DMT overview

Research

Lysergic Acid Diethylamide, Psilocybin and Dimethyltryptamine in Depression Treatment: A Systematic Review

Pharmaceuticals August 12, 2021 Gniewko Więckiewicz, Iga Stokłosa, Magdalena Piegza et al. 30 citations

Despite many different kinds of substances available for depression treatment, depression itself still appears to be a clinical challenge. Recently, formerly illicit substances came to scientists’ attention, including lysergic acid diethylamide (LSD), psilocybin and dimethyltryptamine (DMT). Some studies suggest that these substances might be effective in depression treatment. The aim of this...

N,N-Dimethyltryptamine attenuates spreading depolarization and restrains neurodegeneration by sigma-1 receptor activation in the ischemic rat brain.

Neuropharmacology July 1, 2021 Írisz Szabó, Viktória É Varga, Szabolcs Dvorácskó et al. 67 citations

Dimethyltryptamine (DMT), an endogenous ligand of sigma-1 receptors (Sig-1Rs), acts against systemic hypoxia, but whether DMT may prevent cerebral ischemic injury is unexplored. Here global forebrain ischemia was created in anesthetized rats and aggravated with the induction of spreading depolarizations (SDs) and subsequent short hypoxia before reperfusion. Drugs (DMT, the selective Sig-1R...

DOI: 10.1016/j.neuropharm.2021.108612 (opens in new tab) Full text (opens in new tab) Cerebral ischemia N,N-Dimethyltryptamine Sigma-1 receptor Spreading depolarization +1

An Encounter with the Other: A Thematic Analysis of Accounts of DMT Experiences from a Naturalistic Field Study

June 10, 2021 P. Michael, David Luke, Oliver Robinson 1 citation preprint

Introduction: N, N-Dimethyltryptamine (DMT) is an endogenous serotonergic psychedelic capable of producing radical shifts in conscious experience. Increasing trends in its use, as well as new trials administering DMT to patients, indicate the growing importance of a thorough elucidation of the phenomenology the drug may occasion. This is particularly in light of the hyper-real, otherworldly,...

DMT und Ayahuasca

Suchttherapie May 1, 2021

[ Abb. 1 ] zeigt die Strukturformel, die Anwendungsarten und die handelsüblichen Formen von DMT (Dimethyltryptamin). Substanz Tryptaminhaltige Pflanzen wurden über mehrere 1000 Jahre von südamerikanischen Ureinwohnern bei religiösen Ritualen und zu medizinischen Zwecken eingenommen. Ziel dabei war die Provokation visionärer Erlebnisse als Kontaktaufnahme mit einer jenseitigen Welt, z. B. um die...

Baseline power of theta oscillations predicts mystical-type experiences induced by DMT

bioRxiv Preprint Server March 11, 2021 Enzo Tagliazucchi, Federico Zamberlán, Federico Cavanna et al. 3 citations preprint

N,N-Dimethyltryptamine (DMT) is a classic psychedelic capable of inducing short-lasting but profound changes in consciousness. As with other psychedelics, the experience induced by DMT strongly depends upon contextual factors, yet the neurobiological determinants of this variability remain unknown. We combined wireless electroencephalography and source imaging to map changes in neural...

The DMT and Psilocin Treatment Changes CD11b+ Activated Microglia Immunological Phenotype

bioRxiv Preprint Server March 7, 2021 Urszula Kozłowska, Aleksandra Klimczak, Kalina Wiatr et al. 27 citations preprint

Psychedelics are new, promising candidate molecules for clinical use in psychiatric disorders such as Treatment-Resistant Depression (TRD) and Post Traumatic Stress Disorder (PTSD). They were recently also proposed as molecules supporting neural tissue repair by anti-inflammatory properties. Here we reported that two classic psychedelics, DMT and psilocin, can influence microglial functions by...

Neural and subjective effects of inhaled N,N-dimethyltryptamine in natural settings.

Journal of Psychopharmacology February 10, 2021 Carla Pallavicini, Federico Cavanna, Federico Zamberlán et al. 73 citations

BACKGROUND: N,N-dimethyltryptamine is a short-acting psychedelic tryptamine found naturally in many plants and animals. Few studies to date have addressed the neural and psychological effects of N,N-dimethyltryptamine alone, either administered intravenously or inhaled in freebase form, and none have been conducted in natural settings. AIMS: Our primary aim was to study the acute effects of...

A Phase 1, Dose-Ranging Study to Assess Safety and Psychoactive Effects of a Vaporized 5-Methoxy-N, N-Dimethyltryptamine Formulation (GH001) in Healthy Volunteers.

Frontiers in Pharmacology 2021 Johannes T. Reckweg, Natasha L. Mason, Cees van Leeuwen et al. 58 citations

5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) is a tryptamine with ultra-rapid onset and short duration of psychedelic effects. Prospective studies for other tryptamines have suggested beneficial effects on mental health outcomes. In preparation for a study in patients with depression, the present study GH001-HV-101 aimed to assess the impact of four different dose levels of a novel vaporized...

Synthesis and Characterization of 5-MeO-DMT Succinate for Clinical Use

ACS Omega December 2, 2020 Alexander M. Sherwood, Romain Claveau, Rafael Lancelotta et al. 38 citations

To support clinical use, a multigram-scale process has been developed to provide 5-MeO-DMT, a psychedelic natural product found in the parotid gland secretions of the toad, Incilius alvarius. Several synthetic routes were initially explored, and the selected process featured an optimized Fischer indole reaction to 5-MeO-DMT freebase in high-yield, from which the 1:1 succinate salt was produced...

DOI: 10.1021/acsomega.0c05099 (opens in new tab) Yield engineering High-performance liquid chromatography Salt chemistry Active ingredient +8